Silver Creek Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
Silver Creek Pharmaceuticals General Information
Description
Operator of a biotechnology firm intended to develop therapies that improve the body's healing response and repair damaged tissue. The company offers novel regenerative medicines that stimulate stem cell-based regeneration of cardiovascular tissues after a cardiac infarction, providing patients with the required therapies to protect or repair heart tissue following a heart attack.
Contact Information
Website
www.silvercreekpharma.comCorporate Office
- 329 Oyster Point Boulevard
- Suite 300
- South San Francisco, CA 94080
- United States
Corporate Office
- 329 Oyster Point Boulevard
- Suite 300
- South San Francisco, CA 94080
- United States
Silver Creek Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Jan-2025 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC | 11-Feb-2022 | Completed | Clinical Trials - Phase 2 | |||
| 6. Accelerator/Incubator | Completed | Clinical Trials - Phase 2 | ||||
| 5. Secondary Transaction - Private | 10-May-2019 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series C) | 05-Feb-2018 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC (Series B) | 01-Apr-2015 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 15-Mar-2015 | $221K | $19M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC (Series A) | 21-Apr-2014 | $19M | $19M | Completed | Clinical Trials - Phase 2 |
Silver Creek Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 19,836,652 | $0.000100 | $0.07 | $1 | $1 | 1x | $1 | 49.59% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Silver Creek Pharmaceuticals Patents
Silver Creek Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026112345-A1 | Methods of treatment using igf-1 chimeric proteins | Pending | 20-Nov-2024 | ||
| AU-2024214275-A1 | Methods of treatment using igf-1 chimeric proteins | Pending | 02-Feb-2023 | ||
| EP-4658295-A2 | Methods of treatment using igf-1 chimeric proteins | Pending | 02-Feb-2023 | ||
| EP-4658295-A4 | Methods of treatment using igf-1 chimeric proteins | Pending | 02-Feb-2023 | ||
| US-20260226132-A1 | Methods of treatment using igf-1 chimeric proteins | Pending | 02-Feb-2023 | C07K14/65 |
Silver Creek Pharmaceuticals Signals
Silver Creek Pharmaceuticals Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Catalytik Group | Venture Capital | Minority | ||
| National Heart, Lung, and Blood Institute | Government | |||
| QB3 | Accelerator/Incubator | Minority |
Silver Creek Pharmaceuticals FAQs
-
When was Silver Creek Pharmaceuticals founded?
Silver Creek Pharmaceuticals was founded in 2010.
-
Where is Silver Creek Pharmaceuticals headquartered?
Silver Creek Pharmaceuticals is headquartered in South San Francisco, CA.
-
What is the size of Silver Creek Pharmaceuticals?
Silver Creek Pharmaceuticals has 12 total employees.
-
What industry is Silver Creek Pharmaceuticals in?
Silver Creek Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Silver Creek Pharmaceuticals a private or public company?
Silver Creek Pharmaceuticals is a Private company.
-
What is Silver Creek Pharmaceuticals’s current revenue?
The current revenue for Silver Creek Pharmaceuticals is .
-
How much funding has Silver Creek Pharmaceuticals raised over time?
Silver Creek Pharmaceuticals has raised $57.1M.
-
Who are Silver Creek Pharmaceuticals’s investors?
Catalytik Group, National Heart, Lung, and Blood Institute, and QB3 have invested in Silver Creek Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process